SELLAS Life Sciences (SLS) Income from Continuing Operations (2020 - 2023)
Historic Income from Continuing Operations for SELLAS Life Sciences (SLS) over the last 7 years, with Q4 2023 value amounting to -$8.2 million.
- SELLAS Life Sciences' Income from Continuing Operations rose 1343.43% to -$8.2 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$37.9 million, marking a year-over-year increase of 972.82%. This contributed to the annual value of -$37.9 million for FY2023, which is 830.97% up from last year.
- SELLAS Life Sciences' Income from Continuing Operations amounted to -$8.2 million in Q4 2023, which was up 1343.43% from -$9.4 million recorded in Q3 2023.
- In the past 5 years, SELLAS Life Sciences' Income from Continuing Operations ranged from a high of -$2.2 million in Q1 2021 and a low of -$16.7 million during Q1 2022
- Moreover, its 4-year median value for Income from Continuing Operations was -$7.7 million (2022), whereas its average is -$7.6 million.
- Per our database at Business Quant, SELLAS Life Sciences' Income from Continuing Operations surged by 4475.89% in 2021 and then plummeted by 64543.43% in 2022.
- Over the past 4 years, SELLAS Life Sciences' Income from Continuing Operations (Quarter) stood at -$4.2 million in 2020, then tumbled by 179.37% to -$11.6 million in 2021, then grew by 18.7% to -$9.4 million in 2022, then grew by 13.43% to -$8.2 million in 2023.
- Its last three reported values are -$8.2 million in Q4 2023, -$9.4 million for Q3 2023, and -$9.0 million during Q2 2023.